StreetInsider.com News Articles

Form 3 Sofgen Pharma S.A. For: Mar 18 Filed by: Palacios Luis Alberto

Mon, 30 Mar 2026 17:29:00 -0400

si-local-file:///var/storage/secattach/20260330/26240809.html

Form 3 Sofgen Pharma S.A. For: Mar 18 Filed by: Eguiguren Alberto

Mon, 30 Mar 2026 13:59:00 -0400

si-local-file:///var/storage/secattach/20260330/26240031.html

Form 3 Sofgen Pharma S.A. For: Mar 18 Filed by: Garcia Iragorri Carlos

Mon, 30 Mar 2026 08:11:00 -0400

si-local-file:///var/storage/secattach/20260330/26237552.html

Form 3 Sofgen Pharma S.A. For: Mar 18 Filed by: Bernal Jaramillo Daniel Augusto

Mon, 30 Mar 2026 08:10:00 -0400

si-local-file:///var/storage/secattach/20260330/26237545.html

Form 3 Sofgen Pharma S.A. For: Mar 18 Filed by: Moreira Muniz Fernando Sebastian

Mon, 30 Mar 2026 08:09:00 -0400

si-local-file:///var/storage/secattach/20260330/26237538.html

Form 3 Sofgen Pharma S.A. For: Mar 18 Filed by: Vial Claro Manuel Jose

Thu, 26 Mar 2026 16:40:00 -0400

si-local-file:///var/storage/secattach/20260326/26225189.html

Form 3 Sofgen Pharma S.A. For: Mar 18 Filed by: Romero Camacho Carlos

Thu, 26 Mar 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260326/26225178.html

Form 6-K Procaps Group, S.A. For: Feb 03

Mon, 03 Feb 2025 09:00:00 -0400

si-local-file:///var/storage/secattach/20250203/24284316.html

Form 6-K Procaps Group, S.A. For: Feb 03

Mon, 03 Feb 2025 09:00:00 -0400

si-local-file:///var/storage/secattach/20250203/24284316.html

Procaps Group (PROC) Receives Nasdaq Delisting Notice

Mon, 03 Feb 2025 08:53:58 -0400

Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) that it has determined to delist the Company’s ordinary shares on Nasdaq. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5250(c)(1) and 5250(c)(2) for failing to file periodic and interim financial reports. As a result of the forgoing, the Company’s ordinary shares are expected to commence trading on the Expert Market operated by the OTC Markets Group, Inc. (“OTC”),

Procaps Group Receives Delisting Notice From Nasdaq

Mon, 03 Feb 2025 08:50:00 -0400

MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) that it has determined to delist the Company’s ordinary shares on Nasdaq. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5250(c)(1) and 5250(c)(2) for failing to file periodic and interim financial reports. As a result of the forgoing, the Company’s ordinary shares are expected to commence

Procaps Group Receives Delisting Notice From Nasdaq

Mon, 03 Feb 2025 08:50:00 -0400

Procaps Group Receives Delisting Notice From Nasdaq

Mon, 03 Feb 2025 08:50:00 -0400

Procaps Group Receives Delisting Notice From Nasdaq

Mon, 03 Feb 2025 08:50:00 -0400

Form 6-K Procaps Group, S.A. For: Jan 17

Tue, 21 Jan 2025 06:00:00 -0400

si-local-file:///var/storage/secattach/20250121/24225431.html

Form 6-K Procaps Group, S.A. For: Jan 17

Tue, 21 Jan 2025 06:00:00 -0400

si-local-file:///var/storage/secattach/20250121/24225431.html

Form 6-K Procaps Group, S.A. For: Jan 16

Thu, 16 Jan 2025 08:30:00 -0400

si-local-file:///var/storage/secattach/20250116/24215024.html

Form 6-K Procaps Group, S.A. For: Jan 16

Thu, 16 Jan 2025 08:30:00 -0400

si-local-file:///var/storage/secattach/20250116/24215024.html

Form 6-K Procaps Group, S.A. For: Jan 03